The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Open accessAbstract
Bisphosphonates stop bone loss by inhibiting the activity of bone resorbing osteoclasts. However, the effect of bisphosphonates on bone mass cannot completely explain the reduction in fracture incidence observed in patients treated with these agents. Recent research efforts provided an explanation to this dichotomy by demonstrating that part of the beneficial effect of bisphosphonates on the skeleton is due to prevention of osteoblast and osteocyte apoptosis. Work of our group, independently confirmed by other investigators, demonstrated that bisphosphonates are able to prevent osteoblast and osteocyte apoptosis in vitro and in vivo. This pro-survival effect is strictly dependent on the expression of connexin (Cx)43, as demonstrated in vitro using cells lacking Cx43 or expressing dominant negative mutants of the protein as well as in vivo using Cx43 osteoblast/osteocyte-specific conditional knock-out mice. Remarkably, this Cx43-dependent survival effect of bisphosphonates is independent of gap junctions and results from opening of Cx43 hemichannels. Hemichannel opening leads to activation of the kinases Src and extracellular signal-regulated kinases (ERKs), followed by phosphorylation of the ERK cytoplasmic target p90RSK kinase and its substrates BAD and C/EBPβ, resulting in inhibition of apoptosis. The anti-apoptotic effect of bisphosphonates is separate from the effect of the drugs on osteoclasts, as analogs that lack anti-resorptive activity are still able to inhibit osteoblast and osteocyte apoptosis in vitro. Furthermore, a bisphosphonate analog that does not inhibit osteoclast activity prevented osteoblast and osteocyte apoptosis and the loss of bone mass and strength induced by glucocorticoids in mice. Preservation of the bone forming function of mature osteoblasts and maintenance of the osteocytic network, in combination with lack anti-catabolic actions, open new therapeutic possibilities for bisphosphonates in the treatment of osteopenic conditions in which decreased bone resorption is not desired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 2×
“Moreover, osteocyte apoptosis is increased inconditionsof increasedbone fragility, such as osteoporosis due to excess of glucocorticoids [44] and sex steroid deficiency [52,53].”
Background(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Russell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Self-citationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
(2018) · Wiley eBooks · doi:10.1002/9781119266594 · Cited by 1,105
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Self-citationDunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 900
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 7×
“Mechanistic studies have demonstrated that ERK activation is required for the prevention of osteoblast and osteoclast apoptosis by bisphosphonates, as pharmacological or genetic inhibition ofMEK, the kinase that activates ERKs, abolished the antiapoptotic effect of bisphosphonates [58,61].”
BackgroundInfluentialSelf-citationCummings, S. R., Karpf, D. B., Harris, F., Genant, H. K., Ensrud, K., LaCroix, A. Z., & Black, D. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01124-x · Cited by 752
Kousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 746
Beyond the gap: functions of unpaired connexon channels
Goodenough, D. A., & Paul, D. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1072 · Cited by 729
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids
Almeida, M., Han, L., Martin-Millan, M., Plotkin, L. I., Stewart, S. A., Roberson, P. K., Kousteni, S., O'Brien, C. A., Bellido, T., Parfitt, A. M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702810200 · Cited by 706
Self-citationGap junctions: structure and function (Review)
Evans, W. H., & Martin, P. E. M. (2002) · Molecular Membrane Biology · doi:10.1080/09687680210139839 · Cited by 695
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Establishment of an osteocyte-like cell line, MLO-Y4
Kato, Y., Windle, J. J., Koop, B. A., Mundy, G. R., & Bonewald, L. F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.12.2014 · Cited by 500
Aguirre, J. I., Plotkin, L. I., Stewart, S. A., Weinstein, R. S., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060107 · Cited by 494
Self-citationThe Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.3128 · Cited by 416
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni, M., Guenther, H. L., Fleisch, H., Collin, P., & Martin, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116422 · Cited by 412
Balena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., & Frankenfield, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116872 · Cited by 396
Osteoblast proliferation and maturation by bisphosphonates
Im, G.-I., Qureshi, S. A., Kenney, J., Rubash, H. E., & Shanbhag, A. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.024 · Cited by 393
Noble, B. S., Peet, N., Stevens, H. Y., Brabbs, A., Mosley, J. R., Reilly, G. C., Reeve, J., Skerry, T. M., & Lanyon, L. E. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00234.2002 · Cited by 381
Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307444200 · Cited by 378
Self-citationReinholz, G. G., Getz, B., Pederson, L. G., Sanders, E. S., Subramaniam, M., Ingle, J. N., & Spelsberg, T. C. (2000) · PubMed · Cited by 366
Felsenberg, D., & Boonen, S. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.020 · Cited by 341
Transduction of Cell Survival Signals by Connexin-43 Hemichannels
Plotkin, L. I., Manolagas, S. C., & Bellido, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108625200 · Cited by 334
Self-citation(2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.x0001-8 · Cited by 332
Viereck, V., Emons, G., Lauck, V., Frosch, K.-H., Blaschke, S., Gründker, C., & Hofbauer, L. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6510 · Cited by 310
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
ASBMR (2008) · Wiley eBooks · doi:10.1002/9780470623992 · Cited by 309
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
Vitte, C. (1996) · Endocrinology · doi:10.1210/en.137.6.2324 · Cited by 299
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
Plotkin, L. I., Mathov, I., Aguirre, J. I., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00278.2004 · Cited by 273
Self-citationKousteni, S., Li, H., Chen, J., Almeida, M., Plotkin, L. I., Bellido, T., & Manolagas, S. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17261 · Cited by 270
Self-citationGiuliani, N., Pedrazzoni, M., Negri, G., Passeri, G., Impicciatore, M., & Girasole, G. (1998) · Bone · doi:10.1016/s8756-3282(98)00033-7 · Cited by 269
A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells
Miura, M., Chen, X.-D., Allen, M. R., Bi, Y., Gronthos, S., Seo, B.-M., Lakhani, S., Flavell, R. A., Feng, X.-H., Robey, P. G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420427 · Cited by 262
Functional Gap Junctions Between Osteocytic and Osteoblastic Cells
Yellowley, C. E., Li, Z., Zhou, Z., Jacobs, C. R., & Donahue, H. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.209 · Cited by 259
Plotkin, L. I., Aguirre, J. I., Kousteni, S., Manolagas, S. C., & Bellido, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412817200 · Cited by 240
Self-citationWatts, N. B., Cooper, C., Lindsay, R., Eastell, R., Manhart, M. D., Barton, I. P., van Staa, T.-P., & Adachi, J. D. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:3:255 · Cited by 229
Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure
Recker, R. R., Delmas, P. D., Halse, J., Reid, I. R., Boonen, S., García-Hernandez, P. A., Supronik, J., Lewiecki, E. M., Ochoa, L., Miller, P., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070906 · Cited by 225
Connexin43 mediates direct intercellular communication in human osteoblastic cell networks.
Civitelli, R., Beyer, E. C., Warlow, P. M., Robertson, A. J., Geist, S. T., & Steinberg, T. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116406 · Cited by 223
Plotkin, L. I., Lezcano, V., Thostenson, J., Weinstein, R. S., Manolagas, S. C., & Bellido, T. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080617 · Cited by 214
Self-citationAminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro
Idris, A. I., Rojas, J., Greig, I. R., van’t Hof, R. J., & Ralston, S. H. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9104-y · Cited by 203
Apoptosis during bone-like tissue development in vitro
Lynch, M. P., Capparelli, C., Stein, J. L., Stein, G. S., & Lian, J. B. (1998) · Journal of Cellular Biochemistry · Cited by 173
Rogers, M. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0024-1 · Cited by 164
Plotkin, L. I., Manolagas, S. C., & Bellido, T. (2006) · Bone · doi:10.1016/j.bone.2006.02.060 · Cited by 162
Self-citationBisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., & Nagata, N. (1996) · Bone · doi:10.1016/8756-3282(95)00426-2 · Cited by 161
Storm, T., Steiniche, T., Thamsborg, G., & Melsen, F. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080211 · Cited by 160
Pan, B.-Q., Farrugia, A. N., To, L. B., Findlay, D. M., Green, J., Lynch, K., & Zannettino, A. C. W. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2004.19.1.147 · Cited by 157
Inhibition of osteoblast function in vitro by aminobisphosphonates
Orriss, I. R., Key, M. L., Colston, K. W., & Arnett, T. R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21983 · Cited by 134
Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts
Fromigué, O., & Body, J. J. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345497 · Cited by 130
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
Gourion‐Arsiquaud, S., Allen, M. R., Burr, D. B., Vashishth, D., Tang, S. Y., & Boskey, A. L. (2009) · Bone · doi:10.1016/j.bone.2009.11.011 · Cited by 120
Pan, B.-Q., To, L. B., Farrugia, A. N., Findlay, D. M., Green, J., Gronthos, S., Evdokiou, A., Lynch, K., Atkins, G. J., & Zannettino, A. C. W. (2003) · Bone · doi:10.1016/j.bone.2003.08.013 · Cited by 117
Pozzi, S., Vallet, S., Mukherjee, S., Cirstea, D. D., Vaghela, N., Santo, L., Rosen, E., Ikeda, H., Okawa, Y., Kiziltepe, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0426 · Cited by 117
Effect of alendronate on cultured normal human osteoblasts
García-Moreno, C., Serrano, S., Nacher, M., Farré, M., Díez‐Pérez, A., Mariñoso, M. L., Abelló, J. C., Mellibovsky, L., Nogués, X., Soleda, J. B., et al. (1998) · Bone · doi:10.1016/s8756-3282(97)00270-6 · Cited by 116
Weinstein, R. S. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.621 · Cited by 111
Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis
Kogianni, G., Mann, V., Ebetino, F. H., NUTTALL, M. E., Nijweide, P. J., Simpson, H., & Noble, B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.048 · Cited by 110
Structure-function relationships in the osteocyte.
Marotti, G., Canè, V., Palazzini, S., & Palumbo, C. (1990) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 108
Boyce, R. W., Paddock, C. L., Gleason, J. R., Sletsema, W. K., & Eriksen, E. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100207 · Cited by 99
van Beek, E. R., Löwik, C. W. G. M., Que, I., & Papapoulos, S. E. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111016 · Cited by 94
Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading
Follet, H., Li, J., Phipps, R. J., Hui, S. L., Condon, K. W., & Burr, D. B. (2006) · Bone · doi:10.1016/j.bone.2006.12.052 · Cited by 90
Effects of Alendronate on the Proliferation and Osteogenic Differentiation of MG-63 Cells
Xiong, Y., Yang, H., Feng, J., Shi, Z., & Wu, L. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700216 · Cited by 88
Mathov, I., Plotkin, L. I., Sgarlata, C., Leoni, J., & Bellido, T. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.11.2050 · Cited by 88
Self-citationSu, M., Borke, J. L., Donahue, H. J., Li, Z., Warshawsky, N. M., Russell, C. M., & Lewis, J. E. (1997) · Journal of Dental Research · doi:10.1177/00220345970760070501 · Cited by 86
Plotkin, L. I., Bivi, N., & Bellido, T. (2010) · Bone · doi:10.1016/j.bone.2010.08.011 · Cited by 82
Self-citationAlendronate Modulates Osteogenesis of Human Osteoblastic Cells In Vitro
Tsuchimoto, M., Azuma, Y., Higuchi, O., Sugimoto, I., Hiraia, N., Kiyoki, M., & Yamamoto, I. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.25 · Cited by 78
Alendronate Enhances Osteogenic Differentiation of Bone Marrow Stromal Cells: A Preliminary Study
Kim, H. K., Kim, J. H., Abbas, A. A., & Yoon, T. R. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0409-y · Cited by 71
Valkealahti, M., Mönkkönen, H., Mönkkönen, J., Leskelä, H., Parikka, V., Hämäläinen, M. M. J., & Lehenkari, P. P. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_176.x · Cited by 69
Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells
Gangoiti, M. V., Cortizo, A. M., Arnol, V., Felice, J. I., & McCarthy, A. D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.031 · Cited by 63
Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro
Tenenbaum, H. C., Torontali, M., & Sukhu, B. D. (1992) · Bone · doi:10.1016/8756-3282(92)90205-b · Cited by 58
Igarashi, K., Hirafuji, M., Adachi, H., Shinoda, H., & Mitani, H. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90508-1 · Cited by 55
Greiner, S. H., Kadow‐Romacker, A., Lübberstedt, M., Schmidmaier, G., & Wildemann, B. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30950 · Cited by 53
Long-term effects of neridronate on human osteoblastic cell cultures
Frediani, B., Spreafico, A., Capperucci, C., Chellini, F., Gambera, D., Ferrata, P., Baldi, F., Falsetti, P., Santucci, A., Bocchi, L., et al. (2004) · Bone · doi:10.1016/j.bone.2004.06.001 · Cited by 48
Pantschenko, A. G., Zhang, W., Nahounou, M., McCarthy, M. B., Stover, M. L., Lichtler, A. C., Clark, S. H., & Gronowicz, G. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050315 · Cited by 47
Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis
Bravenboer, N., Papapoulos, S. E., Holzmann, P. J., et al. (1999) · Osteoporosis International · doi:10.1007/s001980050175 · Cited by 43
Reinholz, G. G., Getz, B. J., Sanders, E. S., Karpeisky, M. Y., Padyukova, N. S., Mikhailov, S. N., Ingle, J. N., & Spelsberg, T. C. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014418017382 · Cited by 41
Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures
Itoh, F., Aoyagi, S., Furihata-Komatsu, H., Aoki, M., Kusama, H., Kojima, M., & Kogo, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.011 · Cited by 41
Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria
D'Aoust, P., McCulloch, C. A. G., Tenenbaum, H. C., & Lekic, P. (2000) · Cell and Tissue Research · doi:10.1007/s004419900165 · Cited by 38
Boyce, B. F., Hughes, D. E., Wright, K. R., Xing, L., & Dai, A. (1998) · Springer eBooks · doi:10.1007/978-3-662-09007-7_3 · Cited by 37
Chaplet, M., Detry, C., Deroanne, C., Fisher, L. W., Castronovo, V., & Bellahcène, A. (2004) · Biochemical Journal · doi:10.1042/bj20040380 · Cited by 37
Brown, R. J., van Beek, E., Watts, D. J., Löwik, C. W. G. M., & Papapoulos, S. E. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.2.253 · Cited by 27
Zhang, W., Pantschenko, A. G., McCarthy, M.-B., & Gronowicz, G. (2007) · Calcified Tissue International · doi:10.1007/s00223-006-0168-2 · Cited by 25
Fujita, T., Izumo, N., Fukuyama, R., Meguro, T., Yasutomi, C., Nakamuta, H., & Koida, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.86.86 · Cited by 23
Abe, Y., Kawakami, A., Nakashima, T., Ejima, E., Fujiyama, K., Kiriyama, T., Ide, A., Sera, N., Usa, T., Tominaga, T., et al. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.109757 · Cited by 23
Transcriptome and Proteome Analysis of Osteocytes Treated with Nitrogen-Containing Bisphosphonates
Bivi, N., Bereszczak, J. Z., Romanello, M., Zeef, L. A. H., Delneri, D., Quadrifoglio, F., Moro, L., Brancia, F. L., & Tell, G. (2009) · Journal of Proteome Research · doi:10.1021/pr8005606 · Cited by 21
Cited by
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Robling, A. G., & Bonewald, L. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034332 · Cited by 539
Osteocyte-Driven Bone Remodeling
Bellido, T. (2014) · Calcified Tissue International · doi:10.1007/s00223-013-9774-y · Cited by 384
Self-citationThe osteocyte as a signaling cell
Delgado-Calle, J., & Bellido, T. (2022) · Physiological Reviews · doi:10.1152/physrev.00043.2020 · Cited by 261
Self-citationBone metastasis in prostate cancer: emerging therapeutic strategies
Sturge, J., Caley, M. P., & Waxman, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.67 · Cited by 256
Metadata
- Authors
- Bellido, T., & Plotkin, L. I.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 49
- Issue
- 1
- Pages
- 50-55
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2081071444
- Cited by
- 265
- References
- 82
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.